A new smartphone application using artificial intelligence is presented as a tool to help identify deadly skin cancers. The technology is described as an extension of earlier software called “Derm AI,” which has already been used by the health service in real-world screening and clinical settings. According to the reports, the earlier Derm AI system is associated with detecting around 20,000 skin cancers in more than 230,000 patients. The articles do not provide additional details on the smartphone app’s specific performance metrics, regulatory status, or how it is intended to be deployed, such as whether it is used by clinicians or patients directly. They also do not specify which types of skin cancer are included beyond describing them as deadly skin cancers. The shared information focuses on the scale of prior use of Derm AI and the reported detection figures from that experience. Overall, the coverage indicates that the new app builds on an existing AI tool already used in a large patient population.